Keto (Ketoprofen)

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Keto (Ketoprofen)

This section defines the identity, classification, and fundamental action of the single-entity drug Ketoprofen (INN).

Property Description
Active ingredient Ketoprofen (racemic mixture)
Form Capsules, Tablets, Gel, Solution
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
General purpose Pain, inflammation, and fever relief
Origin Synthetic (Propionic Acid Derivative)

The Identity of Ketoprofen: An NSAID Classification

Ketoprofen is a powerful Nonsteroidal Anti-inflammatory Drug (NSAID) used to modulate the body’s response to pain, inflammation, and fever. It is classified chemically as a synthetic propionic acid derivative. The substance is primarily a racemic mixture of two molecular forms, with the (S)-enantiomer providing the majority of the drug's therapeutic benefit. This particular structure is clinically recognized for its potent analgesic and anti-inflammatory properties, distinguishing it within the broad NSAID class. Popular prescription and over-the-counter (OTC) brands containing Ketoprofen, such as Orudis and Oruvail, highlight its widespread use.

Composition and Available Preparations

Ketoprofen is a single-active-ingredient compound available in multiple preparations for both systemic and local therapeutic effect. The core composition centers on the active ingredient, Ketoprofen, formulated with various non-active components suitable for the intended route of administration. Its availability across different dosage form(s)—including oral capsules and tablets, topical gels, and injectable solutions—indicates its versatility in clinical settings. For instance, the topical gel formulation is often positioned for localized discomfort, offering a distinct delivery method compared to the systemic absorption provided by oral tablets.

General Purpose and Core Physiological Action

The general purpose of Ketoprofen is to reduce the physiological manifestations of tissue damage by inhibiting the generation of key inflammatory signals. Its mechanism is defined by a triple therapeutic action: providing an analgesic effect (pain relief), an anti-inflammatory effect (reduction of swelling), and an antipyretic effect (fever reduction). By acting as a Cyclooxygenase Inhibitor, Ketoprofen blocks the enzyme pathways responsible for producing prostaglandins, the critical local mediators of these three symptoms. The core conclusion is that the medicine fundamentally supports the body's recovery by dampening the pain and inflammation cascade.

Advertisements

What side effects are possible with Keto (Ketoprofen)?

Keto (Ketoprofen): Possible Side Effects and Safety Information

Ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID), carries significant safety warnings from regulatory authorities. Official labeling includes a Boxed Warning concerning the potential for serious, life-threatening cardiovascular and gastrointestinal adverse events.


Serious and Clinically Significant Adverse Reactions

  • Cardiovascular Thrombotic Events: NSAIDs may increase the risk of serious, potentially fatal cardiovascular thrombotic events, including myocardial infarction (MI) and stroke. This risk can increase with the duration of use. Ketoprofen is contraindicated for treating pain immediately before or after coronary artery bypass graft (CABG) surgery.
  • Gastrointestinal Risk: There is an increased risk of serious, sometimes fatal, gastrointestinal (GI) adverse events, including bleeding, ulceration, and perforation of the stomach or intestines. These can occur without warning symptoms at any time.
  • Hepatic and Renal Effects: The drug can cause serious liver injury (hepatotoxicity) and may lead to new onset or worsening of renal failure or hypertension.
  • Severe Skin Reactions: Serious skin reactions such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) have been reported.
  • Hypersensitivity: Anaphylaxis and other serious allergic reactions can occur.

Common Adverse Reactions

Commonly reported side effects (affecting 1% to 10% of users) generally involve the gastrointestinal and nervous systems. These include dyspepsia (a very common reaction), nausea, abdominal pain, diarrhea, constipation, headache, dizziness, and somnolence.


Population-Specific Safety Considerations

  • Elderly Patients: Are at a greater risk for serious GI adverse events and are more likely to have reduced renal function, which may necessitate lower doses and close monitoring.
  • Pregnancy: Use of the drug is generally advised against from around 20 weeks gestation onward due to potential harm to the unborn baby (fetal renal dysfunction and premature closure of the ductus arteriosus).

The established safety profile indicates that the potential for severe, dose- and duration-related risks to the cardiovascular and GI systems is a critical factor in the prescribed use of Ketoprofen.

Advertisements

Overdose and Emergency Response

Documented Clinical Manifestations

Acute Ketoprofen overdose is officially documented to present with systemic signs that primarily involve the gastrointestinal and central nervous systems. Clinical findings include:

  • Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain, and stomach pain.
  • Central Nervous System: Drowsiness, dizziness, headache, confusion, and agitation.
  • Sensory: Tinnitus (ringing in the ears) and blurred vision.

Severe Outcomes and Required Action

Overdose can lead to severe and potentially life-threatening outcomes, including Gastrointestinal (GI) hemorrhage and acute renal failure. Serious central nervous system events such as seizures and coma are also documented in severe cases. Regulatory guidance mandates that immediate medical attention must be sought if an overdose is suspected or if severe symptoms such as vomiting blood, chest pain, or loss of consciousness occur. The national poison control helpline should be contacted immediately.


Official Management Strategy

The official prescribing information confirms that no specific antidote is known for Ketoprofen overdose. Therefore, management is defined as strictly symptomatic and supportive. This strategy may involve procedures like gastric lavage and the administration of activated charcoal. Continuous monitoring of vital signs, blood chemistry, and organ function is typically required following acute toxicity. Population-specific notes indicate that individuals with renal impairment and elderly patients may face an increased risk of toxicity.

Advertisements

Therapeutic Uses of Keto (Ketoprofen)

What Keto (Ketoprofen) Treats: Main Uses and Benefits

Ketoprofen is commonly used across conditions presenting with systemic or localized discomfort, providing supportive therapeutic benefit for the symptoms of chronic conditions like rheumatoid arthritis and osteoarthritis. It helps address symptom clusters that become more disruptive during flare-ups, specifically by easing joint stiffness and is relevant for easing symptoms related to physical discomfort and inflammatory states.

The medication is also applied across domains where additional symptomatic support is needed for acute and episodic discomfort, including symptoms related to physical discomfort associated with menstrual cramps (dysmenorrhea) and dental pain, and generalized symptoms such as fever and muscle aches. This medication is relevant in contexts involving heightened systemic burden, assisting with the discomfort following procedures like post-operative or postpartum recovery.

“The medication supports the patient during difficult episodes by easing the symptom load.”

This supportive use may assist with maintaining functional stability and helps patients cope more steadily with symptom fluctuations, supporting general well-being during symptomatic phases. The primary therapeutic domains include areas involving musculoskeletal inflammation, acute pain episodes, and fever.


Quick Fact: Symptomatic Management of Discomfort
Ketoprofen is often used during phases when symptoms become more noticeable, offering supportive relief when pain or inflammation interferes with routine activities.

Regulatory References

  1. NIH MedlinePlus Drug Information overview
Advertisements

Eligibility and Restrictions for Use

Ketoprofen's eligibility is determined by strict regulatory criteria focusing on a patient's physiological status and comorbidities. The medicine is contraindicated and must not be used by patients with a known hypersensitivity to Ketoprofen or other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including those with aspirin-induced asthma or urticaria. Absolute prohibitions also apply to patients with active peptic ulcers, active inflammatory gastrointestinal disease, or individuals undergoing treatment for peri-operative pain following CABG surgery. Use is also strictly contraindicated during the third trimester of pregnancy.

Regarding age-based eligibility, systemic use of Ketoprofen is not established as safe or effective in the pediatric population (typically below 18 years). While older adults are eligible, they are considered a higher-risk group due to increased susceptibility to gastrointestinal and kidney complications, generally necessitating a reduced initial dose. Furthermore, patients with severe renal or hepatic impairment are subject to explicit regulatory dose limitations and require close monitoring to maintain conditional eligibility. Use during the first and second trimesters of pregnancy or while breastfeeding is generally not recommended and requires caution.

Advertisements

What should I know about interactions with other medicines?

Official Interaction Profile for Ketoprofen

The official interaction profile for Ketoprofen is defined by classifications related to additive pharmacodynamic risk and altered systemic exposure. The use of Ketoprofen is formally contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery, representing a strict procedural constraint documented in regulatory labeling.

Documented Pharmacodynamic and Exposure-Altering Interactions

Interaction Type Interacting Agents (Examples) Official Outcome Description
Additive GI/Bleeding Risk Anticoagulants (Warfarin), SSRIs, Oral Corticosteroids, other NSAIDs, Aspirin Increases risk of hemorrhage and serious GI adverse events.
Reduced Clearance Lithium, Methotrexate, Probenecid Ketoprofen decreases renal clearance, leading to increased plasma concentrations of the co-administered medicine.
Antagonism of Effect Diuretics, ACE Inhibitors, ARBs May diminish the antihypertensive or diuretic effect of the co-administered medicine.

Co-administration with other NSAIDs and Aspirin is strongly advised against due to the combined risk of severe GI complications. Furthermore, consumption of alcohol is documented to increase the potential for GI adverse effects and hemorrhage. Pharmacokinetically, Ketoprofen is documented not to induce drug-metabolizing enzymes. The regulatory profile notes that drug conjugates accumulate in the elderly and in patients with renal insufficiency due to documented reduced renal clearance, which can increase systemic exposure.

Advertisements

Mechanism of Action

How Ketoprofen Works: The Core Mechanism

Ketoprofen exerts its influence primarily through enzyme-mediated signaling, engaging mechanisms that modulate overactive or dysregulated physiological processes within the eicosanoid pathway. The mechanism is characterized by its direct effect on key enzymatic targets and the resulting suppression of specific signaling cascades.

Inhibition of Cyclooxygenase (COX) Enzymes

This domain covers the drug's action on its primary biological targets: the COX-1 and COX-2 enzymes. By blocking these enzymes, Ketoprofen modifies an early molecular step, which leads to predictable physiological adjustments and reduces the concentration of downstream mediators.

Modulation of Prostaglandin Synthesis

This focuses on the key pathway effect where the COX enzyme inhibition immediately suppresses the conversion of arachidonic acid. This action alters signaling dynamics in the eicosanoid pathway, resulting in altered signaling dynamics within defined biochemical processes and the modulation of thermoregulatory and nociceptive pathway activity .

Influence on the Lipoxygenase (LOX) Pathway

This describes Ketoprofen's additional, though less pronounced, mechanistic domain. By also acting on the LOX pathway, Ketoprofen contributes to a broader range of mediator concentration adjustments, affecting systems where specific transmitters (leukotrienes) dominate, which influences the overall pattern of eicosanoid cascade modulation.

Advertisements

Dosage and Administration Information

Ketoprofen administration is characterized by several routes, primarily oral (capsules, tablets) and topical (gel). The systemic use of the medication involves two distinct dosing structures: the immediate-release (IR) form and the extended-release (ER) form. The IR capsule is used for scheduled daily dosing in chronic conditions (e.g., 75 mg three times daily) or on an intermittent, as-needed basis for acute, short-term use. In contrast, the ER capsule is reserved for once-daily maintenance therapy (200 mg QD) and is specifically not recommended for acute pain management due to its delayed absorption profile.

Maximum daily intake is restricted to 300 mg per day for the IR form and 200 mg per day for the ER form. Administration of the oral capsule may occur with food or an antacid; this method delays the rate of absorption without altering the total amount of drug absorbed.

Dose reductions are utilized for specific populations to standardize systemic exposure. A lower starting dose is applicable for older adults due to expected changes in drug clearance. Likewise, the maximum daily dose is reduced for individuals with established hepatic or renal impairment. Should a dose be missed, the standard approach is to resume the regular schedule and avoid taking a double dose at the next interval.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Keto (Ketoprofen)


Evidence for Use in Chronic Musculoskeletal and Inflammatory Conditions

Research exploring how symptoms change in chronic conditions such as Osteoarthritis and Rheumatoid Arthritis typically involves Randomized Controlled Trials (RCTs) and thorough Systematic Reviews. These studies primarily focus on adult populations experiencing conditions characterized by fluctuating manifestations. The outcomes monitored include patient-reported outcomes describing perceived discomfort, changes in joint stiffness, and assessments of overall daily functioning or activity level.

The findings from these studies describe patterns observed in the studies related to outcomes related to physical discomfort and functional measures. Research highlights changes measured during the study period. The evidence structure for these indications includes a large volume of available research, mainly RCTs.

However, data regarding sustained outcomes are limited. There is limited information for long-term outcomes regarding the sustained study effects on function or symptom control, as follow-up durations were limited in many initial trials.


Evidence for Use in Acute and Post-Procedural Pain

Research for acute and sudden pain episodes, such as post-operative pain and menstrual cramps (dysmenorrhea), primarily consists of short-term RCTs and Meta-Analyses. These studies are relevant in trials assessing short-term or episodic symptom patterns. The key outcomes monitored include the time taken for a measured change in symptoms to be observed, the duration of pain relief studied, and outcomes describing episodic or acute changes in discomfort.

Studies conducted during periods of increased symptom activity reported how symptoms evolved in the observed populations. Research provides insight into short-term changes. What remains uncertain is the comparative evidence across all potential acute pain scenarios, and extended observation periods beyond the immediate acute phase are not fully established.


What Research Gaps and Uncertainties Remain

As noted, there is limited information for long-term outcomes, especially regarding the pattern of effects over time. The follow-up durations were limited in many studies, meaning that the pattern of effects during extended use is not as well-established as the short-term outcomes. Furthermore, the results apply only to the populations studied, and data for certain comorbidity groups or populations outside of the general adult demographic remain insufficient.

Key Studies & References Ketoprofen Drug Information Overview

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Keto (Ketoprofen) (FAQ)


Q: What is Keto (Ketoprofen) and how does it work?

Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking the production of certain natural substances in the body that cause inflammation, pain, and fever. It is commonly used to treat symptoms of conditions such as rheumatoid arthritis and osteoarthritis.


Q: What is the most common side effect of Ketoprofen?

The most common side effects associated with Ketoprofen are usually related to the gastrointestinal tract. These can include upset stomach, nausea, indigestion, and stomach pain. To minimize these effects, it is often recommended to take Ketoprofen with food or milk.


Q: Does Ketoprofen interact with blood thinners like Warfarin?

Yes, Ketoprofen can interact significantly with blood thinners such as Warfarin. Taking Ketoprofen while on Warfarin can increase the risk of serious bleeding, including bleeding in the stomach or intestines. It is critical to inform your healthcare provider about all medications, including over-the-counter pain relievers, you are taking before starting Ketoprofen.


Q: Can I take Ketoprofen if I have high blood pressure?

Ketoprofen, like other NSAIDs, may cause your body to retain water and salt, which can potentially increase your blood pressure or make existing high blood pressure worse. If you have high blood pressure (hypertension), you should discuss the risks with your healthcare provider before taking Ketoprofen. Regular blood pressure monitoring may be necessary while you are taking this medication.


Q: Is Ketoprofen safe to take during pregnancy?

Taking Ketoprofen is generally not recommended during pregnancy, especially during the third trimester (after 20 weeks). NSAIDs taken late in pregnancy may cause problems for the developing fetus, particularly issues with the fetal kidneys and the ductus arteriosus (a blood vessel in the heart). You should consult with a healthcare professional immediately if you are pregnant or planning to become pregnant while taking Ketoprofen.

Advertisements

How should Keto (Ketoprofen) be stored and disposed of?

Storage Requirements

Ketoprofen must be stored at Controlled Room Temperature, defined as 20^circ to 25 C (68^circ to 77 F), with permitted excursions. It is essential to protect the product from excessive heat, moisture, and light. Keep the medicine in its original container, ensuring it remains tightly closed and away from damp areas.

For child safety, the product must be stored out of the sight and reach of children and secured with a child-resistant closure.

Disposal Instructions

Do not keep or use outdated medicine past its expiration date. Patients should consult a healthcare professional or pharmacist for specific disposal guidance. Disposal should utilize an official drug take-back program if available. If not, follow authorized household disposal procedures, such as mixing the medicine with an undesirable substance, sealing it, and discarding it in the trash. Do not flush Ketoprofen down the toilet or pour it down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Keto (Ketoprofen) found in:

A-Z Index: